Kevin P. Kerns

Array ( [id] => 8618342 [patent_doc_number] => 20130023654 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-24 [patent_title] => 'ANTIBODIES TO MATRIX METALLOPROTEINASE 9' [patent_app_type] => utility [patent_app_number] => 13/619318 [patent_app_country] => US [patent_app_date] => 2012-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10135 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13619318 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9635666 [patent_doc_number] => 20140213775 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-31 [patent_title] => 'INTRACELLULAR CELL SELECTION' [patent_app_type] => utility [patent_app_number] => 14/241215 [patent_app_country] => US [patent_app_date] => 2012-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7345 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14241215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8618335 [patent_doc_number] => 20130023647 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-24 [patent_title] => 'MODIFIED HUMAN THYMIC STROMAL LYMPHOPOIETIN' [patent_app_type] => utility [patent_app_number] => 13/608808 [patent_app_country] => US [patent_app_date] => 2012-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12802 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13608808 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11560523 [patent_doc_number] => 09623083 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-04-18 [patent_title] => 'Method to screen for an activator of adipose-resident NK cells' [patent_app_type] => utility [patent_app_number] => 14/241482 [patent_app_country] => US [patent_app_date] => 2012-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 11896 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 214 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14241482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8684392 [patent_doc_number] => 20130052676 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-28 [patent_title] => 'Composition and Method for Assessing Regulation of Mast Cells' [patent_app_type] => utility [patent_app_number] => 13/596048 [patent_app_country] => US [patent_app_date] => 2012-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6097 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13596048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8522244 [patent_doc_number] => 20120321652 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-20 [patent_title] => 'PEPTIDES FOR ACTIVE ANTI-CYTOKINE IMMUNIZATION' [patent_app_type] => utility [patent_app_number] => 13/593823 [patent_app_country] => US [patent_app_date] => 2012-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6616 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13593823 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9126633 [patent_doc_number] => 08574579 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-05 [patent_title] => 'Anti-IL-23 antibodies' [patent_app_type] => utility [patent_app_number] => 13/587370 [patent_app_country] => US [patent_app_date] => 2012-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 33817 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13587370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11231226 [patent_doc_number] => 09458447 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-10-04 [patent_title] => 'MPHOSPH1 peptides and vaccines including the same' [patent_app_type] => utility [patent_app_number] => 14/131019 [patent_app_country] => US [patent_app_date] => 2012-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 4 [patent_no_of_words] => 32148 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14131019 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11656093 [patent_doc_number] => 09669077 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-06-06 [patent_title] => 'Method for treating chronic colitis and systemic sclerosis and for eliciting a protective immune reaction against human IL-6' [patent_app_type] => utility [patent_app_number] => 14/237942 [patent_app_country] => US [patent_app_date] => 2012-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 10039 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14237942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10938822 [patent_doc_number] => 20140341843 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-20 [patent_title] => 'PURIFIED PROTEINS' [patent_app_type] => utility [patent_app_number] => 14/235777 [patent_app_country] => US [patent_app_date] => 2012-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 50662 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14235777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8489474 [patent_doc_number] => 20120288881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-15 [patent_title] => 'Method for Evaluating the Cure Level of Stroke' [patent_app_type] => utility [patent_app_number] => 13/558931 [patent_app_country] => US [patent_app_date] => 2012-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5269 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13558931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11463867 [patent_doc_number] => 09580485 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-02-28 [patent_title] => 'IL-12 immunoconjugate' [patent_app_type] => utility [patent_app_number] => 14/234081 [patent_app_country] => US [patent_app_date] => 2012-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 11579 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14234081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9602638 [patent_doc_number] => 20140199320 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-17 [patent_title] => 'MODULATORS OF THE NLRP3 INFLAMMASOME IL-1BETA PATHWAY FOR THE PREVENTION AND TREATMENT OF ACNE' [patent_app_type] => utility [patent_app_number] => 14/232272 [patent_app_country] => US [patent_app_date] => 2012-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 7051 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14232272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8828627 [patent_doc_number] => 20130129672 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-23 [patent_title] => 'MUTANTS OF INTERLEUKIN- 1 RECEPTOR ANTAGONIST AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/545878 [patent_app_country] => US [patent_app_date] => 2012-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 22405 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13545878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8482865 [patent_doc_number] => 20120282272 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-08 [patent_title] => 'NOVEL TARGET IN THE TREATMENT OF CYTOKINE RELEASE SYNDROME' [patent_app_type] => utility [patent_app_number] => 13/544823 [patent_app_country] => US [patent_app_date] => 2012-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5202 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13544823 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8465051 [patent_doc_number] => 20120270219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'NOVEL GENES ENCODING PROTEINS HAVING PROGNOSTIC, DIAGNOSTIC, PREVENTIVE, THERAPEUTIC, AND OTHER USES' [patent_app_type] => utility [patent_app_number] => 13/540352 [patent_app_country] => US [patent_app_date] => 2012-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 38216 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13540352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8853080 [patent_doc_number] => 20130142755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-06 [patent_title] => 'Methods for Improving Immune Function and Methods for Prevention or Treatment of Disease in a Mammalian Subject' [patent_app_type] => utility [patent_app_number] => 13/533784 [patent_app_country] => US [patent_app_date] => 2012-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 39867 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13533784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12305961 [patent_doc_number] => 09938353 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-04-10 [patent_title] => Compositions, methods and uses for alpha-1 antitrypsin fusion molecules [patent_app_type] => utility [patent_app_number] => 14/125135 [patent_app_country] => US [patent_app_date] => 2012-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 19378 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14125135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8982274 [patent_doc_number] => 08513389 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-20 [patent_title] => 'Engineered anti-IL-23p19 antibodies' [patent_app_type] => utility [patent_app_number] => 13/530854 [patent_app_country] => US [patent_app_date] => 2012-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 25216 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13530854 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8611896 [patent_doc_number] => 20130017208 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-17 [patent_title] => 'Anti-IL-6 Antibodies, Compositions, Methods and Uses' [patent_app_type] => utility [patent_app_number] => 13/524684 [patent_app_country] => US [patent_app_date] => 2012-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 44920 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13524684 [rel_patent_id] =>[rel_patent_doc_number] =>)